What compliance requirements commonly apply to life sciences companies?

Depending on your data and partners, life sciences firms may need to align with requirements such as HIPAA (if handling PHI), FDA 21 CFR Part 11 (for certain electronic records/signatures), and SOC 2 expectations driven by customers or investors.

Does SOC 2 readiness affect IT operations for biotech companies?

Yes. SOC 2 readiness typically requires clearer access controls, logging, documented policies, vendor management, and repeatable operational processes. Many firms implement stronger monitoring and documentation to satisfy audits and questionnaires.

How should life sciences companies approach compliance without slowing innovation?

Start with high-impact controls (MFA, EDR, backups), document key policies, and standardize onboarding/offboarding and vendor access. A phased approach builds defensible security while keeping teams productive.

Compliance Requirements - Life Sciences

Life sciences companies in Massachusetts may need to comply with HIPAA, FDA 21 CFR Part 11, SOC 2, ISO 27001, and GDPR, depending on their business model. For 10–100 employee biotech and medical device firms, compliance readiness projects typically range from $25,000 to $150,000+, with timelines averaging 3–9 months.

HIPAA (If Handling PHI)

Applies if:

Managing clinical patient data
Running healthcare-related trials

Requires:

Encryption
Access controls
Audit logs
Risk assessments

FDA 21 CFR Part 11

Applies when:

Using electronic records & signatures
Supporting regulated device or pharma workflows

Requires:

Secure audit trails
Access documentation
Validation procedures

SOC 2 for Investors & Partnerships

Increasingly required during:

Series A/B funding
Enterprise partnerships

Preparation typically costs:

$30,000–$120,000+

ISO 27001

International standard for information security.

Implementation cost range:

$50,000–$150,000+

Real Example

A 60-employee biotech preparing for Series B implemented SOC 2 readiness in 6 months at approximately $85,000 total investment and successfully passed investor cybersecurity review.